SPONSOR
Peter Rossing
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 4
Conditions studied: Cardiovascular Autonomic NeuropathyType 2 DiabetesDiabetic NeuropathiesChronic Kidney Disease(CKD)
Peter Rossing is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Cardiovascular Autonomic Neuropathy, Type 2 Diabetes, Diabetic Neuropathies, Chronic Kidney Disease(CKD).
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peter Rossing
How many clinical trials has Peter Rossing sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Peter Rossing, of which 2 are actively recruiting participants. These trials cover conditions including Cardiovascular Autonomic Neuropathy, Type 2 Diabetes, Diabetic Neuropathies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peter Rossing research focus on?
Peter Rossing clinical trials span Cardiovascular Autonomic Neuropathy, Type 2 Diabetes, Diabetic Neuropathies, Chronic Kidney Disease(CKD). The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peter Rossing clinical trial?
To participate in a Peter Rossing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peter Rossing trials with current recruitment status updated daily.
Clinical Trials by Peter Rossing
NCT06906081 Phase 2
Recruiting
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Cardiovascular Autonomic Neuropathy
NCT07239570 Phase 4
Recruiting
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Chronic Kidney Disease(CKD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology